» Articles » PMID: 25437920

Role of Protein Phosphorylation in Excitation-contraction Coupling in Taurine Deficient Hearts

Overview
Date 2014 Dec 2
PMID 25437920
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Taurine is a beta-amino acid found in very high concentration in the heart. Depletion of these intracellular stores results in the development of cardiomyopathy, thought to be mediated by abnormal sarcoplasmic reticular (SR) Ca(2+) transport. There is also evidence that taurine directly alters the Ca(2+) sensitivity of myofibrillar proteins. Major regulators of SR Ca(2+) ATPase (SERCA2a) are the phosphorylation status of a regulatory protein, phospholamban, and SERCA2a expression, which are diminished in the failing heart. The failing heart also exhibits reductions in myofibrillar Ca(2+) sensitivity, a property regulated by the phosphorylation of the muscle protein, troponin I. Therefore, we tested the hypothesis that taurine deficiency leads to alterations in SR Ca(2+) ATPase activity related to reduced phospholamban phosphorylation and expression of SERCA2a. We found that a sequence of events, which included elevated protein phosphatase 1 activity, reduced autophosphorylation of CaMKII, and reduced phospholamban phosphorylation, supports the reduction in SR Ca(2+) ATPase activity. However, the reduction in SR Ca(2+) ATPase activity was not caused by reduced SERCA2a expression. Taurine transporter knockout (TauTKO) hearts also exhibited a rightward shift in the Ca(2+) dependence of the myofibrillar Ca(2+) ATPase, a property that is associated with an elevation in phosphorylated troponin I. The findings support the observation that taurine deficient hearts develop systolic and diastolic defects related to reduced SR Ca(2+) ATPase activity, a change mediated in part by reduced phospholamban phosphorylation.

Citing Articles

Taurine and Polyphenol Complex Repaired Epidermal Keratinocyte Wounds by Regulating IL8 and TIMP2 Expression.

Lee S, Shin J, Kwon O, Jun S, Kang N Curr Issues Mol Biol. 2024; 46(8):8685-8698.

PMID: 39194729 PMC: 11352352. DOI: 10.3390/cimb46080512.


Novel VEGFR2 inhibitors with thiazoloquinoxaline scaffold targeting hepatocellular carcinoma with lower cardiotoxic impact.

El-Hazek R, Zaher N, El-Gazzar M, Fadel N, El-Sabbagh W Sci Rep. 2023; 13(1):13907.

PMID: 37626064 PMC: 10457369. DOI: 10.1038/s41598-023-40832-z.


Natural aging and ovariectomy induces parallel phosphoproteomic alterations in skeletal muscle of female mice.

Peyton M, Yang T, Higgins L, Markowski T, Murray K, Vue C Aging (Albany NY). 2023; 15(15):7362-7380.

PMID: 37580837 PMC: 10457050. DOI: 10.18632/aging.204959.


Ant-Neointimal Formation Effects of SLC6A6 in Preventing Vascular Smooth Muscle Cell Proliferation and Migration via Wnt/β-Catenin Signaling.

Rong Z, Li F, Zhang R, Niu S, Di X, Ni L Int J Mol Sci. 2023; 24(3).

PMID: 36769341 PMC: 9917619. DOI: 10.3390/ijms24033018.


Dynamic but discordant alterations in zDHHC5 expression and palmitoylation of its substrates in cardiac pathologies.

Main A, Boguslavskyi A, Howie J, Kuo C, Rankin A, Burton F Front Physiol. 2022; 13:1023237.

PMID: 36277202 PMC: 9581287. DOI: 10.3389/fphys.2022.1023237.